ArticleOncotarget2018

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer.

Oliver C Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.